PATENT CLAIM ANALYSIS

Application Number: 15755636
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "243000"]

Abstract:
The invention relates generally to compounds that modulate the activity of TGFBETA R-1 and TGFBETA R-2, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.

Claim (Index 14):
The use according to  claim 13  wherein the cancer is small cell lung cancer, non-small cell lung cancer, triple-negative breast cancer, ovarian cancer, colorectal cancer, prostate cancer, melanoma, pancreatic cancer, multiple myeloma, T-acute lymphoblastic leukemia or AML.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 88.0
- Lexical Diversity: 1.45161
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15747843', '14977709', '15430883', '14190477', '15746597']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7626617503197848
- 35 USC 102 Novelty (BERT): 0.5483507122310605
- Combined Prediction Score: 0.7412306465109124
- Mean Citation Score: 304.519028
- Max Citation Score: 385.2536
- Similarity Product: 314.66014504237177

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test